Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9ca869056216a723c83289f730cc132 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 |
filingDate |
2006-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cec4d6e98dbbc6ba2667a5d7ec341579 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6fa0b76f7499a47281b09044afd5ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf222d893ff239fd12e6b98723734c77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb62a40923d82fb634a282ecce44fca7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3a4431589d4a18b881d721222700c45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_816ba34a1c6ad92c8eb4225e80e79945 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834d6499a2c990f830829001c02dd28e |
publicationDate |
2008-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1941877-A1 |
titleOfInvention |
Pharmaceutical compositions containing nitrovinylfuran derivatives for the treatment of leishmaniasis and trypanosomiasis |
abstract |
The present invention describes the action of a new family of drugs against a number of Leishmania species and Trypanosoma cruzi, for the treatment of cutaneous, mucocutaneous and visceral leishmaniosis as well as tripanosomosis. In vitro assays and studies conducted in animal models and in human patients demonstrated that the compounds had a higher activity compared to drugs in clinical use against Leishmania mexicana amazonensis, L. donovani infantum, L. braziliensis braziliensis and Trypanosoma cruzi. n The pharmaceutical activity of compositions based on such family of compounds was evidenced and supports its human and veterinary application for the treatment of the above-mentioned diseases by using different administration routes. |
priorityDate |
2005-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |